Skip to content

Author

Davide Capodanno

5 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Omega-3 Fatty Acids in the Management of Cardiovascular Disease Prevention.

PURPOSE Omega-3 polyunsaturated fatty acids lower triglycerides and modulate inflammation, thrombosis, and endothelial function, providing a rationale for their use in cardiovascular prevention. This review examines the influence of formulation, dose, and patient selection on clinical outcomes. METHODS A targeted Pub...

S. Finocchiaro, L. Cutore, C. Bordonaro et al. · 0 citations
Review Open access Sep 2026

Sex-based differences in acute coronary syndrome: mechanisms, management, and outcomes.

INTRODUCTION Acute coronary syndrome (ACS) remains a leading cause of morbidity and mortality worldwide. Sex- and gender-related differences in ACS persist and encompass risk profiles, clinical presentation, management, and outcomes. AREAS COVERED PubMed was searched from database inception through May 2026 for relev...

K. Bujak, C. Bordonaro, M. S. Mauro et al. · 0 citations
Review Aug 2026

Catheter-Based Left Atrial Appendage Closure vs Oral Anticoagulation in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Importance In patients with atrial fibrillation (AF), oral anticoagulation (OAC) is the gold standard for preventing ischemic stroke, at the expense of a higher risk of bleeding. Catheter-based left atrial appendage closure (LAAC) has been proposed as an alternative strategy to prevent stroke, but the efficacy and safe...

C. Laudani, K. Bujak, D. Giacoppo et al. · 1 citation
Review Jul 2026

Anticoagulant regimen for non-valvular atrial fibrillation in the elderly and frail population.

In elderly and frail patients with AF, DOACs represent the first-line anticoagulant therapy when appropriately dosed and monitored, and future trials specifically enrolling very old and severely frail patients are urgently needed to close existing evidence gaps.

L. Scalia, Laura Gatto, Federica Agnello et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.